Glycoprotein IIb/IIIa inhibitors in acute myocardial infarction and angiographic microvascular obstruction: the REVERSE-FLOW trial
Ingo Eitel(German Centre for Cardiovascular Research), Thomas Stiermaier(University Hospital Schleswig-Holstein), Christian Frerker(University Hospital Schleswig-Holstein), Thomas Kurz(University of Lübeck), Harm Wienbergen(University of the Arts Bremen), Dominik Jurczyk(University Hospital Schleswig-Holstein), Christoph Marquetand(University of Lübeck), Hölger Thiele(Leipzig Heart Institute), Rainer Hambrecht(Leipzig University of Applied Sciences), Abdelhakim Allali(Segeberger Kliniken), Alexander Joost(University of Lübeck), Philip Haaf(University of Basel), Steffen Desch(Leipzig Heart Institute), Christian Mueller(Immutep (Germany)), Gregor Fahrni(University of Basel), Roza Saraei(German Centre for Cardiovascular Research), Andreas Fach(University of the Arts Bremen), Tobias Schmidt(Asklepios Fachklinikum Brandenburg)
Cited by 24
Related Papers
Intraaortic Balloon Support for Myocardial Infarction with Cardiogenic Shock
|New England Journal of Medicine|2012|2.8k
Contemporary Management of Cardiogenic Shock: A Scientific Statement From the American Heart Association
|Circulation|2017|1.8k
Regular physical exercise and low-fat diet. Effects on progression of coronary artery disease.
|Circulation|1992|1.3k
Effect of Exercise on Coronary Endothelial Function in Patients with Coronary Artery Disease
|New England Journal of Medicine|2000|1.3k
2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
|European Heart Journal|2022|1.1k